Home › Non-Small Cell Lung Cancer › Pennsylvania › New Castle

Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa New Castle, PA

4 pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng New Castle (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Nagre-recruitPhase 3

UPMC Hillman Cancer Center - New Castle, New Castle

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT04267848

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

Nagre-recruitPhase 2

UPMC Hillman Cancer Center - New Castle, New Castle

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07293247

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Nagre-recruitPhase 2

UPMC Hillman Cancer Center - New Castle, New Castle

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Nagre-recruitPhase 2/3

UPMC Hillman Cancer Center - New Castle, New Castle

Edad 18 pataas · Lahat ng kasarian · Na-update May 5, 2026 · NCT06616584

Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod

Iba pang pag-aaral sa New Castle

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.